Maurizio Bonati is professor of public health at the Istituto di Ricerche Farmacologiche Mario Negri IRCSS in Milan, Italy.
Maurizio Bonati
Professor
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
From this contributor
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
By
Maurizio Bonati
7 May 2019 | 5 min read
Explore more from The Transmitter
Researchers retract multisensory learning paper after failed replications
Even though one set of experiments did not hold up, the authors stand by the original conclusions of the work and plan to resubmit it as a new paper.
Researchers retract multisensory learning paper after failed replications
Even though one set of experiments did not hold up, the authors stand by the original conclusions of the work and plan to resubmit it as a new paper.
By
Calli McMurray
31 March 2026 | 4 min read
Cortical evolution, ZBTB18, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 30 March.
Cortical evolution, ZBTB18, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 30 March.
By
Jill Adams
31 March 2026 | 2 min read
Letter asks Congress for nearly $500 million to sustain BRAIN Initiative
The one-time boost would help counter the planned end this year to one of the program’s long-standing funding streams, which will result in a $195 million drop in funding for fiscal year 2027.
Letter asks Congress for nearly $500 million to sustain BRAIN Initiative
The one-time boost would help counter the planned end this year to one of the program’s long-standing funding streams, which will result in a $195 million drop in funding for fiscal year 2027.
By
Angie Voyles Askham
31 March 2026 | 3 min read